Canada’s Blind Spot on Drug Safety in Pregnancy – SOGC
The Society of Obstetricians and Gynaecologists of Canada (SOGC) shared a post on LinkedIn:
“A new op-ed published in the Montreal Gazette, co-authored by SOGC CEO Dr. Diane Francoeur and SOGC member Prof. Anick Bérard, highlights a critical gap in women’s health: the lack of robust data on the safety of medications during pregnancy.
Dr. Francoeur and Prof. Bérard note that most prescription drugs approved in Canada lack adequate safety data for use in pregnancy, leaving patients and physicians to make important decisions without clear evidence.
They call for stronger national data infrastructure, sustained investment in women’s health research and better integration of real-world evidence to change behaviour and improve outcomes.
Read the full op-ed.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
-
Oct 28, 2026, 15:37Gili Band: The People Are What Stay With Me After Day 1 at ASRM 2026
-
Oct 28, 2026, 13:56Samantha Payne: NSW Releases Final Report on Fertility Support and Assisted Reproductive Treatment
-
Oct 28, 2026, 13:53True Friendship and PCOS: Why Emotional Support Matters – PCOS Millennials
-
Oct 28, 2026, 13:51Fred Ushakov: The Future of Prenatal Screening, The Future of Your Practice
-
Oct 28, 2026, 13:49Hosting the First-Ever Fairfax Awards – Fairfax EggBank
